Friday 6 November 2026 Export MEDP’s income statement to Excel — free account

Medpace Holdings, Inc.

Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.

Revenue: +8.50%
EPS: +24.6%
Free cash flow: −16.6%

Quarter to September 2026, against a year earlier

634.63 22.14 −3.37%

Follow MEDP

Alert me

Market cap: $17.8B
P/E: 34.6×
Fwd P/E: 35.8×
Dividend yield: —
F-score: 8/9
Altman Z: 8.04
Beneish M: −2.92
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Medpace Holdings, Inc. (MEDP) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2025: revenue by segment, and margins
Reportable Segment	2,530	100.00%
Gross margin		71.06%
Operating margin		21.14%
Pre-tax margin		21.44%

Revenue by product or service $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Metabolic	748 29.55%	651 30.88%	587 31.13%	468 32.04%	363 31.76%	298 32.15%	257 29.82%	189 26.83%	—	—
Other	745 29.44%	458 21.69%	377 19.98%	245 16.76%	160 14.00%	126 13.62%	139 16.10%	125 17.72%	—	—
Oncology	409 16.15%	431 20.45%	405 21.47%	297 20.34%	267 23.41%	215 23.26%	196 22.78%	164 23.27%	—	—
Cardiology	255 10.07%	182 8.63%	160 8.49%	158 10.82%	122 10.64%	88 9.55%	92 10.66%	54 7.70%	—	—
Central Nervous System	239 9.46%	230 10.93%	194 10.27%	175 11.96%	120 10.48%	95 10.28%	91 10.60%	95 13.51%	—	—
AVAI	135 5.33%	156 7.42%	163 8.66%	118 8.08%	111 9.71%	103 11.15%	86 10.03%	77 10.97%	—	—
Direct Revenue	—	—	—	—	—	—	—	—	386 88.61%	371 87.91%
Reimbursed Out Of Pocket Revenue	—	—	—	—	—	—	—	—	50 11.39%	51 12.09%
Revenue Net	—	—	—	—	1,142	926	861	705	—	—
Revenue	2,530	2,109	1,886	1,460	1,142	926	861	705	436	422

Revenue by segment $m

Line	FY2025	FY2024	FY2023	FY2022
Reportable Segment	2,530 100.00%	2,109 100.00%	1,886 100.00%	1,460 100.00%
Revenue	2,530	2,109	1,886	1,460

Operating income by segment $m, and margin

	FY2025	FY2024	FY2023	FY2022
Reportable Segment	‡	‡	‡	‡
Corporate and other	‡	‡	‡	‡
Operating income	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡

Operating figures as reported in each quarter’s results release or filing

Figure	Quarter	Latest	A year before	Change
Backlog	Q3 FY2026	$3.2B	$3.0B	+5.55%
Backlog conversion rate	Q3 FY2026	23.8%	23.0%	—
Employees	Q3 FY2026	6.6K	6.2K	+6.45%
Net book-to-bill ratio	Q2 FY2026	1.1×	1.0×	+9.71%
Net new business awards	Q3 FY2026	$873.4M	$789.6M	+10.61%
Remaining performance obligations	Q3 FY2026	$3.8B	$3.5B	+8.57%

	Q3 FY2026	Q2 FY2026	Q1 FY2026	Q4 FY2025	Q3 FY2025	Q2 FY2025	Q1 FY2025	Q4 FY2024	Q3 FY2024	Q2 FY2024	Q1 FY2024	Q4 FY2023	Q3 FY2023	Q2 FY2023	Q1 FY2023	Q4 FY2022	Q3 FY2022	Q2 FY2022	Q1 FY2022	Q4 FY2021	Q3 FY2021	Q2 FY2021	Q1 FY2021	Q4 FY2020	Q3 FY2020	Q2 FY2020	Q1 FY2020	Q4 FY2019	Q3 FY2019	Q2 FY2019	Q1 FY2019	Q4 FY2018	Q3 FY2018	Q2 FY2018	Q1 FY2018
Backlog	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Backlog conversion rate	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Employees	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Net book-to-bill ratio	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Net new business awards	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Remaining performance obligations	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.